Abstract
Proteomics, the large-scale study of proteins, their structures, and functions, plays a pivotal role in drug discovery. By providing insights into the molecular mechanisms of diseases and identifying potential biomarkers and therapeutic targets, proteomics enables the development of more effective and precise drugs. This article explores the application of proteomics in drug discovery, focusing on the methods used, the challenges faced, and the potential for future advancements. Special attention is given to the integration of proteomic data with other omics technologies to enhance the drug discovery process. The article also discusses case studies demonstrating the practical applications of proteomics in identifying new drug targets and biomarkers for various diseases.
All articles published in the American Journal of Pharmaceutics are open access and licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows users to:
-
Share — copy and redistribute the material in any medium or format
-
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Under the following terms:
-
Attribution — Appropriate credit must be given, a link to the license must be provided, and any changes must be indicated.
-
Authors retain full copyright of their work.
-
The journal does not restrict reuse of content, provided proper citation of the original publication is made.